GLENMARK PHARMACEUTICALS
Back to Income Statement
|
GLENMARK PHARMACEUTICALS Last 5 Year Revenue History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Sales | ₹11,583 Cr | ₹12,305 Cr | ₹10,944 Cr | ₹10,641 Cr | ₹9,865 Cr |
What is the latest Revenue of GLENMARK PHARMACEUTICALS ?
Year | Revenue |
---|---|
Mar2024 | ₹11,583 Cr |
Mar2023 | ₹12,305 Cr |
Mar2022 | ₹10,944 Cr |
Mar2021 | ₹10,641 Cr |
Mar2020 | ₹9,865 Cr |
How is Revenue of GLENMARK PHARMACEUTICALS Trending?
Years | Revenue | % Change | |
---|---|---|---|
Mar2024 | ₹11,583 Cr | -5.86 | |
Mar2023 | ₹12,305 Cr | 12.44 | |
Mar2022 | ₹10,944 Cr | 2.85 | |
Mar2021 | ₹10,641 Cr | 7.86 | |
Mar2020 | ₹9,865 Cr | - |
Compare Revenue of peers of GLENMARK PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GLENMARK PHARMACEUTICALS | ₹60,513.6 Cr | -3.5% | 25% | 50.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹405,991.0 Cr | -0.1% | 1.3% | 5% | Stock Analytics | |
DIVIS LABORATORIES | ₹175,720.0 Cr | -1.7% | 0.5% | 47.2% | Stock Analytics | |
CIPLA | ₹120,133.0 Cr | 0.4% | -1.5% | -1.6% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹118,994.0 Cr | -0.2% | 9% | 13.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,562.0 Cr | 0.5% | -5.7% | -9.1% | Stock Analytics |
GLENMARK PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GLENMARK PHARMACEUTICALS | -3.5% |
25% |
50.1% |
SENSEX | -0.1% |
0.2% |
2.1% |
You may also like the below Video Courses